Lipitor's Target on HMG-CoA Reductase
Lipitor (atorvastatin) inhibits HMG-CoA reductase, the enzyme that catalyzes the conversion of HMG-CoA to mevalonate in cholesterol biosynthesis. It binds to the enzyme's active site, mimicking the natural substrate HMG-CoA to block this step.
Molecular Structure Enabling Binding
Atorvastatin features a core dihydroxyheptenoic acid side chain resembling HMG-CoA's 3-hydroxy-3-methylglutaryl moiety. In its active, anionic form at physiological pH, the carboxylate group positions like HMG-CoA's diphosphate, while the 3,5-dihydroxyheptanoate chain aligns with the substrate's backbone.[1]
Key Binding Interactions
Crystal structures (e.g., PDB 1HWK) show atorvastatin forming:
- Hydrogen bonds: The carboxylate oxygen atoms hydrogen-bond with His381, Asp690, and Lys691 in the active site, anchoring the HMG-like group. The 1,3-diol forms bonds with Gly590 and a water-mediated link to Asn761.
- Hydrophobic contacts: The atorvastatin pyrrole-fluorophenyl core packs into a hydrophobic pocket involving Val683, Phe688, and Leu857, stabilizing the compact fit.
- Ionic mimicry: The anionic form electrostatically interacts with catalytic residues like Lys691, displacing the substrate.[1][2]
These interactions deform the active site, preventing HMG-CoA from binding and catalysis.
Why Lipitor Binds Tighter Than HMG-CoA
Atorvastatin's lipophilic rings extend into a non-polar channel absent in HMG-CoA, adding ~1000-fold potency (Ki ~5 nM vs. HMG-CoA's Km ~1 μM). This allosteric tightening rigidifies the site.[2]
Differences from Other Statins
Unlike simvastatin (more flexible chain) or rosuvastatin (compact sulfonamide), atorvastatin's rigid pyrrole system optimizes pocket occupancy, explaining its superior affinity (lowest Ki among statins).[3]
Clinical Implications of Binding Mechanism
Tight binding yields long enzyme occupancy (half-life ~14 hours), supporting once-daily dosing and sustained LDL reduction up to 60%.[1]
Sources
[1]: Nature Structural Biology: Crystal structure of HMG-CoA reductase with atorvastatin
[2]: Science: Mechanism of HMG-CoA reductase inhibition by statins
[3]: DrugPatentWatch.com: Atorvastatin patents and statin comparisons